FDA-Cleared Molecular Test Targets Growing US Cyclospora Outbreak
QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.
QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.
Researchers are uncovering how the deadly parasite E. histolytica kills human cells and evades the immune system.
Discover the latest updates on H. pylori infection testing in an exclusive webinar hosted by Meridian Bioscience. Dr. Steven F. Moss and Dr. Colin W. Howden will discuss the new 2024 ACG guidelines, including who to test, how to test, and when to re-test for H. pylori. Learn about non-invasive testing methods and updated treatment protocols to improve patient outcomes.
The FDA approved Genetic Signatures’ EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated workflow for sale in the U.S.
Read MoreAn oral rinse could offer early detection of gastric cancer, the fourth-leading cause of cancer deaths worldwide, according to a new study.
Read MoreBruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read MoreThe Oncoguard Esophagus test showed high sensitivity and specificity for the detection of esophageal adenocarcinoma and its precursors.
Read MoreLucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read MoreBiomerica received FDA 510(k) clearance for a new test designed to detect the presence of the H. pylori bacteria.
Read MoreResearchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease.
Read MoreLaboratory services company PathAI Diagnostics unveiled an AI-assisted LDT for the histologic scoring and staging of MASLD and MASH.Â
Read MoreCOVID-19 has reshaped the global landscape of gastrointestinal infections, notably surging norovirus cases. Coupled with an increasing immunity gap due to reduced vaccinations, healthcare systems are on alert. Seegene offers solutions for these unprecedented challenges.
Read MoreIn an era of rapid technological advancements, the traditional art of morphological diagnosis in parasitology remains crucial. This piece delves into the juxtaposition of modern methods and foundational expertise, emphasizing the need for a harmonious integration in the face of emerging parasitic threats.
Read MoreThe U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.
Read MoreHospital-onset infections still occur—the most common caused by C. diff, the culprit in almost half a million infections yearly in the U.S.
Read MoreCairn Diagnostics’ 13C-Spirulina Gastric Emptying Breath Test was included in ACG Clinical Guidelines for the diagnosis of gastroparesis.
Read MoreDelve into the transformative role of AI in parasitology diagnostics. The research highlights the potential of convolutional neural networks (CNN) in detecting intestinal protozoa, offering insights into improved accuracy and the broader implications for lab professionals. A must-read for those at the intersection of technology and medical diagnostics.
Read MoreDiagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Read More